What should I do if I see a drop of liquid on my skin after injecting
Future research can include randomized controlled trials and see if there are similar effects in other populations
Common Side Effects of Semaglutide According to the FDA, the following precautions need to be taken into account when using Semaglutide: Pancreatitis: Has been reported in clinical trials
Eli Lilly has emerged as Novo Nordisk's primary competitive threat through its tirzepatide program (Mounjaro for Type 2 diabetes, Zepbound for obesity treatment), which demonstrated superior weight loss efficacy of 20 to 22 percent compared to Semaglutide's 10 to 17 percent in clinical trials
Who its for May be a fit if you Are exploring provider-guided weight management Want a dual-pathway option for appetite control Have plateaued on a single-pathway GLP-1 Want licensed provider oversight and ongoing support Not appropriate if you Have a personal or family history of medullary thyroid carcinoma or MEN 2 Are pregnant, trying to conceive, or breastfeeding Have a history of pancreatitis or certain GI conditions (discuss with your provider) Are advised against GLP-1 care by your provider Eligibility is always determined by a licensed provider after reviewing your intake
Other than modeled projections, since there hasnt been a decade long study examining GLP-1s for obesity, we just dont know yet